Engaging With Patient Advocates To Improve Clinical Trials

By Richard Gamble, Project Director and Jean Conger, Global Project Manager

Shrinking budgets and rising drug bills mean that regulators and payers are putting a greater emphasis on proven drug value before they approve a drug or agree to its pricing and reimbursement. This requires drug companies to generate data from clinical trials that reflects real-world use in order to support evidence-based pricing and prescribing.